Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer: Safety lead‐in results from the QUATTRO-II study
Daisuke Kotani, Takayuki Yoshino, Masahito Kotaka, Akihito Kawazoe, Toshiki Masuishi, Hiroya Taniguchi, Kentaro Yamazaki, Takeharu Yamanaka, Eiji Oki, Kei Muro, Yoshito Komatsu, Hideaki Bando, Hironaga Satake, Takeshi Kato, Akihito Tsuji
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読
2
被引用数
(Scopus)